• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Galmed Pharmaceutica (NQ: GLMD )

    0.2887 +0.0034 (+1.19%)
    Streaming Delayed Price Updated: 11:36 AM EDT, Jul 3, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 13,720
    Open 0.3000
    Bid (Size) 0.2860 (69)
    Ask (Size) 0.2919 (1)
    Prev. Close 0.2853
    Today's Range 0.2887 - 0.3000
    52wk Range 0.2600 - 5.470
    Shares Outstanding 5,045,324
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    GLMD Stock Earnings: Galmed Pharmaceuticals Reported Results for Q1 2024
    Galmed Pharmaceuticals just reported results for the first quarter of 2024. 
    Via InvestorPlace
    Why KKR Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
    Via Benzinga

    Performance

    YTD
    -34.34%
    -34.34%
    1 Month
    -19.36%
    -19.36%
    3 Month
    -11.74%
    -11.74%
    6 Month
    -35.69%
    -35.69%
    1 Year
    -90.21%
    -90.21%

    More News

    Read More
    Why PriceSmart Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for April 2024
    Via InvestorPlace
    Why Agenus Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    GLMD Stock Earnings: Galmed Pharmaceuticals Misses EPS for Q4 2023
    Via InvestorPlace
    Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
    Via The Motley Fool
    Gold Rises 1%; Hibbett Shares Spike Higher
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Nasdaq Falls Over 100 Points; Burlington Shares Jump After Q3 Results
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    US Stocks Down; Chicago Fed National Activity Index Falls In October
    Via Benzinga
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Why Galecto Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Via InvestorPlace
    Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
    Via Benzinga
    Nasdaq Drops 50 Points; Wells Fargo Earnings Beat Views
    Via Benzinga
    Crude Oil Down 2%; Citigroup Profit Tops Estimates
    Via Benzinga
    Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Why Is Carvana (CVNA) Stock Down 5% Today?
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.